Skip to main content

Table 4 Cancer detection rate according to PI-RADS v2 score

From: Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study

 

PI-RADS v2 score

1

n = 22

2

n = 11

3

n = 55

4

n = 97

5

n = 30

Insignificant PCa, n (%)

3 (13.6%)

0 (0%)

2 (3.6%)

12 (12.4%)

1 (3.3%)

Significant PCa, n (%)

4 (18.2%)

1 (9.1%)

6 (10.9%)

64 (66.0%)

24 (80.0%)

Total PCa, n (%)

7 (31.8%)

1 (9.1%)

8 (14.5%)

76 (78.3%)

25 (83.3%)

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us